SUTRO BIOPHARMA, INC. - STRO

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$364.4M

QoQ value delta ($000)

+$299.6M (+462.56%)

Implied price effect (QoQ)

+112.23%

Total shares

14,840,167

QoQ shares delta

+9,241,616 (+165.07%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 78 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
BVF INC/IL	31,182	1,251,788	0.99%
Affinity Asset Advisors, LLC	26,641	1,069,519	1.38%
Samsara BioCapital, LLC	26,476	1,062,872	2.57%
Kynam Capital Management, LP	21,735	872,558	1.34%
ORBIMED ADVISORS LLC	19,956	801,144	0.4%
VANGUARD CAPITAL MANAGEMENT LLC	17,946	720,442	0.0%
PERCEPTIVE ADVISORS LLC	17,818	715,307	0.35%
RA CAPITAL MANAGEMENT, L.P.	17,818	715,307	0.19%
EVENTIDE ASSET MANAGEMENT, LLC	17,818	715,307	0.29%
Point72 Asset Management, L.P.	17,240	692,111	0.02%
ADAR1 Capital Management, LLC	13,063	524,441	0.77%
Velan Capital Investment Management LP	12,757	512,160	7.99%
BALYASNY ASSET MANAGEMENT L.P.	11,602	465,792	0.02%
Woodline Partners LP	11,394	457,441	0.04%
UBS Group AG	9,786	392,871	0.0%
ACADIAN ASSET MANAGEMENT LLC	8,363	335,813	0.01%
Merck & Co., Inc.	6,784	272,351	1.94%
ACUTA CAPITAL PARTNERS, LLC	6,711	269,425	4.73%
BlackRock, Inc.	5,796	232,684	0.0%
KVP Capital Advisors, LP	5,643	226,575	4.21%
MARSHALL WACE, LLP	5,545	222,634	0.01%
MILLENNIUM MANAGEMENT LLC	5,240	210,378	0.0%
ADAGE CAPITAL PARTNERS GP, L.L.C.	4,982	200,000	0.01%
Opaleye Management Inc.	4,749	190,671	0.63%
VANGUARD GROUP INC	4,347	375,786	0.0%